Jaguar Health, Inc. (NASDAQ: JAGX), the commercial-stage pharmaceuticals company, offers 100,000 common stock shares on a resale basis. On Tuesday, the company’s shares were trading 3.61% at $1.65 apiece.  In September 2020, the company launched new initiatives called Entheogen Therapeutics to support the development of psychoactive plant-based medicines for mood […]